Skip to main content
. 2025 Nov 14;17(22):3659. doi: 10.3390/cancers17223659
ABL Abelson Tyrosine-Protein Kinase 1
ALK Anaplastic Lymphoma Kinase
AXL Tyrosine-protein kinase receptor UFO
BBB Blood–brain barrier
BCL2 B Cell Lymphoma 2
BCR Breakpoint Cluster Region protein
BRAF B-Raf protein, serine/threonine kinase
BTK Bruton Kinase
CDK Cyclin-Dependent Kinase
CNS Central nervous system
CTLA4 Cytotoxic T-Lymphocyte Associated Protein 4
DDR2 Discoidin Domain Receptor Tyrosine Kinase 2
DFS Disease Free Survival
EGFR/HER1 Epithelial Growth Factor Receptor
EPCAM Epithelial Cell Adhesion Molecule
FDA Food and Drug Administration
FGF Fibroblast growth factors
FILP1 Filamin A Interacting Protein 1
FLT3 Fms Related Receptor Tyrosine Kinase 3
HGFR/MET Hepatocyte Growth Factor Receptor
HRP Horse Radish Peroxidase
KIT KIT proto-oncogene, receptor tyrosine kinase
IDH1 Isocitrate dehydrogenase
JAK Janus Kinase
LAG 3 Lymphocyte Activating 3
LYN Protein tyrosine kinase Src family
MAPK Mitogen-activated protein kinase
MEK Mitogen Activated Protein Kinase Kinase
mTOR Mammalian target of rapamycin
OS Overall Survival
PARP Poly ADP Ribose Polymerase
PD1/PDL1 Programmed Cell Death Protein 1/PD1 Ligand
PDGFR Platelet Derived Growth Factor Receptor
PFS Progression Free Survival
PKC Protein Kinase C
PI Propidium Iodide
PI3K Phosphoinositide 3-kinase
PVDF Polyvinylidene Fluoride
RAF Rapidly Accelerated Fibrosarcoma
RET Rearranged during transfection tyrosine kinase receptor
ROS ROS Proto-Oncogene 1, Receptor Tyrosine Kinase
SMO Smoothened protein
TIM3 T-cell immunoglobulin and mucin-domain containing-3
TRK Tropomyosin Receptor Kinase
VEGFR Vascular Endothelial Growth Factor Receptor